Conference Coverage

Brian Lacy, MD, on a Trisymptom Composite for IBS

05/23/2022

Dr Lacy reviews his poster presentation on a post hoc analysis that evaluates rifaximin for improving a new trisymptom composite endpoint for irritable bowel syndrome combining abdominal pain/discomfort, bloating, and bowel urgency.

Brian Lacy, MD, is a gastroenterologist and professor of medicine at the Mayo Clinic—Jacksonville, in Jacksonville, Florida.

Sign up for our e-Newsletters

Gastroenterology Newsletter

News

Novel AI System Shows Success in Detection of Adenomas

08/27/2024

Jessica Garlewicz ;

CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.

CAD-EYE detection system...

08/27/2024

Gastroenterology

News

Implementation of Fecal Immunochemical Test-Based Program in Colorectal Cancer Screening

08/20/2024

Jessica Garlewicz ;

Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.

Investigators studied whether...

08/20/2024

Gastroenterology

News

Low-Dose Aspirin and Prevention of Colorectal Cancer

08/14/2024

Jessica Garlewicz ;

Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.

Results of a new study showed...

08/14/2024

Gastroenterology

News

FIT Screening Associated With Lower Risk of Death From CRC

08/06/2024

Jessica Garlewicz ;

Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.

Findings of a new study support...

08/06/2024

Gastroenterology

News

FDA Approves First Blood Test for Primary CRC Screening

07/30/2024

Rebecca Mashaw ;

Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.

Shield is the first blood test...

07/30/2024

Gastroenterology

News

Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD

07/24/2024

Jolynn Tumolo ;

Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.

Extended screening and...

07/24/2024

Gastroenterology

News

Ultraprocessed Food Linked to Elevated Risk of CRC

07/24/2024

Jolynn Tumolo ;

C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.

C olorectal cancer, colon...

07/24/2024

Gastroenterology